In the total of 300 breast cancer patients (mean age: 61.5 years), 97 (32.3%) belonged to luminal A, 56 (18.6%) to luminal B, 61 (20.3%) to HER2, and 70 (23.3%) to TN. Here, ERBB2 is linked to breast carcinoma.